OTC Markets OTCPK - Delayed Quote • USD
Ampio Pharmaceuticals, Inc. (AMPE)
At close: May 31 at 12:37 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Michael A. Martino | CEO, CFO, General Secretary & Director | 550k | -- | 1957 |
| Dr. David Bar-Or M.D. | Founder & Chairman of Scientific Advisory Board | 145.6k | -- | 1949 |
| April Ramirez | Clinical Trial Manager | -- | -- | -- |
Ampio Pharmaceuticals, Inc.
9800 Mount Pyramid Court
Suite 400
Englewood, CO 80112
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 6
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Corporate Governance
Ampio Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 6, 2024 at 8:00 PM UTC - August 12, 2024 at 8:00 PM UTC
Ampio Pharmaceuticals, Inc. Earnings Date
Recent Events
April 15, 2024 at 12:00 AM UTC
15-12G: Notice of termination of registration of a class of securities under Section 12(g)
April 4, 2024 at 12:00 AM UTC
25: Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
Related Tickers
FNCH Finch Therapeutics Group, Inc.
0.9670
-0.31%
ARDS Aridis Pharmaceuticals, Inc.
0.0625
+4.17%
IPIX Innovation Pharmaceuticals Inc.
0.0015
0.00%
AZTR Azitra, Inc.
0.1870
-4.10%
CWBR CohBar, Inc.
0.8100
+6.56%
SLRX Salarius Pharmaceuticals, Inc.
0.4632
+0.37%
GRI GRI Bio, Inc.
0.3020
-8.73%
PHRM.CN PharmaTher Holdings Ltd.
0.2150
+4.88%
ORGS Orgenesis Inc.
0.5149
+5.95%
PBLA Panbela Therapeutics, Inc.
0.4000
+5.24%